Innovent Biologics, Inc. 信達生物製藥

Pay for financial year ended 2022-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chen, Kaixian 陳凱先 INED 400 74 474
2 Chen, Nick Shuyun 陳樹云 NED
3 Cooney, Charles Leland INED 400 184 584
4 Ede, Ronald Hao Xi 奚浩 FD 2,485 4,475 22,671 29,631
5 Hsu, Joyce I Yin 許懿尹 INED 400 184 584
6 Yu, Michael De Chao 俞德超 Ch, CEO, Pres 2,899 30,061 106,471 139,431
7 Zieziula, Gary INED 233 441 674
Total 1,433 5,384 34,536 0 130,025 171,378

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2024-12-31 1,867 7,483 42,949 111 143,703 196,113 Report
2023-12-31 1,600 5,489 38,058 0 126,180 171,327 Report
2022-12-31 1,433 5,384 34,536 0 130,025 171,378 Report
2021-12-31 1,122 5,119 26,500 0 116,707 149,448 Report
2020-12-31 1,122 5,241 18,994 0 94,155 119,512 Report
2019-12-31 1,482 5,241 15,540 165 63,644 86,072 Report
2018-12-31 761 4,201 90,765 142 16,996 112,865 Report
Total 9,387 38,158 267,342 418 691,410 1,006,715

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top